O'Connor Madeline J, Huffman Kristin N, Ho Kelly, Marzouk Sammer, Casas Fuentes Rolando J, Zhang Kenneth L, Melnick Bradley A, Sparks Payton J, Harris Raiven, Bartler Angelica V, Collinsworth Ashley, Griffin Leah, Galiano Robert D
From the Department of Surgery/Division of Plastic and Reconstructive Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Ill.
Health Economics and Outcomes Research, Solventum, Maplewood, Minn.
Plast Reconstr Surg Glob Open. 2024 Nov 5;12(11):e6267. doi: 10.1097/GOX.0000000000006267. eCollection 2024 Nov.
Periprosthetic infection after breast reconstruction is not uncommon and can result in loss of the implant pocket and negative patient outcomes. Management of these infections typically involves removal of the prosthesis, treatment with antibiotics, and delayed reconstruction upon infection resolution. The impact of adjunctive use of negative pressure wound therapy with instillation and dwell (NPWTi-d) on breast pocket salvage rates, time to implant reinsertion, and related outcomes was examined.
A systematic literature search using PubMed, Cochrane, OVID, Scopus, and Embase was conducted to identify peer-reviewed articles written in English and published between January 2004 and April 2023 that examined NPWTi-d use in the breast pocket with a history of periprosthetic infection after breast reconstruction.
Of the 1703 publications, 6 studies met inclusion criteria, representing 115 patients and 122 breasts. The overall breast pocket salvage rate with NPWTi-d across studies was approximately 92%. In the 6 studies that included prosthesis type and radiation history, overall salvage rates were 97.8% (45 of 46) for pockets containing implants and 93.8% (15 of 16) for pockets containing tissue expanders. Salvage rates were 85.7% (12 of 14) and 91.7% (53 of 58) for irradiated and nonirradiated breasts, respectively. Mean time to implant reinsertion ranged from 2.3 to 10.3 days.
In this review, antibiotic therapy along with adjunctive use of NPWTi-d for periprosthetic infections after breast reconstructions was associated with high rates of breast pocket salvage and reduced time to implant reinsertion. Larger prospective and randomized trials are needed to better understand and optimize the effectiveness of NPWTi-d in this population.
乳房重建术后假体周围感染并不少见,可能导致植入腔隙丧失及患者预后不良。这些感染的处理通常包括取出假体、使用抗生素治疗,以及在感染消退后延迟重建。本研究探讨了附加使用滴注式负压伤口治疗(NPWTi-d)对乳房腔隙挽救率、植入物重新植入时间及相关结局的影响。
通过PubMed、Cochrane、OVID、Scopus和Embase进行系统文献检索,以识别2004年1月至2023年4月期间发表的、以英文撰写的、探讨NPWTi-d在乳房重建术后有假体周围感染史的乳房腔隙中应用的同行评审文章。
在1703篇出版物中,6项研究符合纳入标准,涉及115例患者和122个乳房。各研究中使用NPWTi-d的总体乳房腔隙挽救率约为92%。在纳入假体类型和放疗史的6项研究中,含植入物腔隙的总体挽救率为97.8%(46个中的45个),含组织扩张器腔隙的总体挽救率为93.8%(16个中的15个)。放疗和未放疗乳房的挽救率分别为85.7%(14个中的12个)和91.7%(58个中的53个)。植入物重新植入的平均时间为2.3至10.3天。
在本综述中,抗生素治疗联合NPWTi-d用于乳房重建术后假体周围感染,与较高的乳房腔隙挽救率及缩短植入物重新植入时间相关。需要更大规模的前瞻性随机试验,以更好地了解并优化NPWTi-d在该人群中的有效性。